Pharma Journalist 8962 posts 0 comments

Fate Therapeutics announced that the U.S. Food and Drug Administration (FDA) has allowed its Investigational New Drug (IND) application for FT516, the Company’s off-the-shelf natural…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb partnership with Genagon Therapeutics AB, an immuno-oncology focused biotech located in Sweden.…
Read More...

Cannabics Pharmaceuticals announced that it has entered into agreement with Wize Pharma, a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and…
Read More...

BioMotiv, a drug development accelerator associated with The Harrington Project for Discovery & Development, and researchers from Rutgers, The State University of New Jersey,…
Read More...

Pathios Therapeutics and Sygnature Discovery sign strategic partnership to discover novel GPR65 modulators for the treatment of autoimmune disease and cancer. Pathios Therapeutics,…
Read More...

When it comes to proving the value of a new medicine, pharma has to strike the right balance This article was written by eyeforpharma There are perhaps few buzzwords bandied…
Read More...

Taiho Pharmaceuticaland Cullinan Oncology announced on February 5 an agreement to develop TAS6417, a novel EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor discovered…
Read More...

SMi is proud to announce the 3rd Annual 3D Cell Culture conference is returning to London in just under two weeks’ time. Researchers globally are realizing the potential of 3D cell…
Read More...

Value has become a buzzword, but its importance cannot be overstated. How do we ensure its survival? The beauty of language lies in the fact that it is personal. The meaning of…
Read More...

Bridging the gap between innovation and access is Percival Barretto-Ko's top priority The way he tells it, Percival Barretto-Ko owes a lot to the profession of teaching. The…
Read More...